Latest Valuation News

Adisyn has moved closer to commercialising its graphene platform after independently verified sub-300°C deposition, a US patent allowance and a new defence technology arm. The progress came alongside a A$7.83 million statutory loss, A$4.47 million in operating cash outflows and a heavily judgement-based A$42.1 million technology asset.

Financial Income Fund delivered a 6.78% net return in the year to 30 June 2026, beating its hybrid securities benchmark by 0.92 percentage points. The audited report also records the launch of an ETF class, higher distributions and a shift away from convertible notes.

Murray Cod Australia posted a $5.37 million FY2026 loss after the prior year’s $8.56 million profit, despite higher fish biomass and improved fourth-quarter performance. The company ended the year with $4.14 million in cash after raising capital, while operating cash outflow reached $26.57 million and a Westpac interest-cover covenant was breached and waived.

Immuron delivered record FY26 sales, a narrower loss and a much stronger cash balance, while shifting clinical development towards commercial partners. The annual report also flags a material weakness in inventory controls and confirms that IMM-529 remains dependent on a future licensing deal.

NoviqTech has secured binding commitments for a $1.805 million share placement, but the raise cannot complete until shareholders approve it. The company remains suspended, and ASX has not agreed that the proposed funding package will be enough for reinstatement.

4DMedical delivered sharp growth in scans, sites and operating revenue as CT:VQ moved into commercial deployment across several global markets. But the company remains loss-making and its auditor issued a qualified opinion over the carrying value of goodwill and other intangible assets.

WAM Capital’s investment portfolio fell 10.5% in FY2026, while Wilson Asset Management set an 8.0 cents per share target for the next financial year. The presentation points to a thin 0.7-year dividend reserve after the final payout, even as management argues small-cap valuations and takeover activity are improving.

WAM Capital reported a 10.5% decline in investment portfolio performance for FY2026, but retained its full-year dividend at 15.5 cents per share. The listed investment company is targeting an 8.0-cent dividend for FY2027, backed by a profits reserve of 5.7 cents per share after the latest payout.

First Sentier Active Cash Fund reported a 56.9% rise in operating profit to $29.1 million for the year ended 30 June 2026, while net assets nearly doubled to $964.1 million. The fund also began trading on the ASX as FSCF during the year, but distributions per unit fell to 4.10 cents from 4.41 cents.

Centuria Office REIT delivered a $55.2 million statutory profit in FY26 and near-record leasing, but its FY27 distribution guidance falls below this year’s payout. The balance sheet is stronger after a $1 billion refinancing, leaving occupancy and rental growth as the key tests ahead.

Centuria Industrial REIT delivered 4% growth in funds from operations for FY26 and expects another lift in FY27, supported by leasing momentum and embedded rental reversion. The opportunity comes with a more exposed interest-rate profile and a development pipeline that still depends on power, planning and execution.

Katana Capital Limited (ASX:KAT) delivered a 17.98% gross investment return in FY2026, beating the All Ordinaries by 15.55 percentage points as its portfolio benefited from defence, infrastructure, resources and technology exposures. Net profit rose to $3.808 million, while the listed investment company entered FY2027 with elevated cash and a deliberately cautious stance on banks.